The development of a cardiovascular risk algorithm such as SCORE or PCE) including remnant cholesterol together with low-density lipoprotein (LDL) cholesterol would help to better identify high-risk individuals who could be candidates for statins in a primary prevention setting, a new analysis of population data suggests.